Warburg Sells Drug Co. Talon In Backloaded $206M Deal
Spectrum Pharmaceuticals Inc. said Wednesday it will buy Talon Therapeutics Inc., a listed drugmaker backed by Warburg Pincus LLC, in a deal worth up to $206.3 million, 95 percent of which...To view the full article, register now.
Already a subscriber? Click here to view full article